Background: Cancer poses a serious threat to human health and survival, and studies had been reported that imidazole or pyridine analogs play as an anti-cancer agent in cancer treatment. Meanwhile, Autophagy plays a dual and substantial role in maintaining cellular homeostasis in cancers, for it is either initiated to rescue cancer cells under stress or executed to promote autophagy cell death under certain circumstances. Objective: TIP-6 was designed and synthesized (7-(4-methoxyphenyl)-5,8α-diphenyl-1,2,3,7,8, 8α-hexahyd-roimidazo[1,2-α]pyridine-6) for evaluation of its biological effects on HepG2 cells and exploring the potential anti-cancer effect. Methods and Results: Chemical synthesis results indicated that the expected compound was obtained. The results of the MTT assay showed that TIP-6 arrested the growth of HepG2 cells in G2/M phase in the cell cycle, showing significant anti-proliferation effect. And analysis of morphological changes and formation of acidic vesicular organelles showed that the autophagy was induced but not apoptosis. The results were further validated by the enhanced expression of LC3I/II, Beclin1and down-regulated expression of Bcl-2in western blot analysis. In addition, the molecular docking predicted that TIP-6 preferentially binds to Bcl-2 and Bcl-xL in the active sites. Conclusion: Overall, this study demonstrated that autophagy cell death was executed in HepG2 cells which were induced by TIP-6.
Introduction
Cancer is a disease involving abnormal cell growth, and inhibiting cell growth or promoting apoptosis which is a fundamental area of cancer research. At present, people try to select potential anticancer drugs from natural products or inorganic compounds. Many studies have shown that imidazole or pyridine analogs have significant anti-cancer effects.
Autophagy is a biological process ever evolved into eukaryotes to maintain the cytoplasmic homeostasis and found plays a tug-of-war game in either promoting cell survival or inducing cell death as a number of genes and proteins are identified and implicated in these two forces [1] [2] [3] . Although autophagy plays a crucial role in the mammalian development and differentiation [4] and evidenced in a wide range of diseases including cancer [5] , the exact biological role of autophagy is still controversial, given that both a prosurvival role and a pro-death role of autophagy are proposed respectively [6] . A large body of evidence demonstrated that well-tuned autophagy is readily programmed for cell survival under physiological condition, while aberrant autophagy is eventually executed to facilitate cell death under pathologic conditions [7] . However, how does autophagy promote or suppress in diseases such as cancer and how autophagy can be biochemically regulated to treat cancer need to be further studied to understand the dual role of autophagy in cancer, thus providing potential novel cancer targets [8] .
Drawing the picture in which how the autophagy is mechanistically regulated in cancer cells is further complicated by the observations of very different scenarios of autophagy modulations in both individual cancer cell types and the cancer development of different stages [9] [10] [11] . Since the autophagy is both constitutively activated and spatiotemporally regulated in a dynamic fashion, a dual role is frequently referred to autophagy in cancer for its being able to rescue cancer cells under stress and, when the apoptosis (Type I programmed cell death) is defective, for its being capable of promoting autophagy cell death (Type II programmed cell death). ATG gene family is principally related to autophagy [12] in yeast and oncogenes like PI3K/AKT, BCL2, Ras and tumor suppressor genes such as TSC1, TSC2, LKB1, PTEN, TP53, and Becn1 are found capable of inhibiting autophagy and inducing autophagy, respectively [13] . Furthermore, Bcl-2 is found both in vitro and in vivo to inhibit autophagy through its interaction with Beclin 1, the autophagy protein in mammalians [14] [15] . Apogossypolone (ApoG2), a small-molecule inhibitor of Bcl-2, is demonstrated to induce autophagy in prostate cancer cell line PC-3 and LNCaP cells [16] .
Based on the above, this study was trying to design and synthesize a com- 
Materials and Methods

Synthesis of TIP-6
The reaction was carried out under nitrogen atmosphere. 4-Methoxybenzaldehyde and acetophenone were purchased from Aldrich and used directly. 
Cell Culture
Human tumor cell lines HepG2 and Hela were obtained from Biology Preservation Center of Shanghai Institute of Material Medical. The passage number is less than 10 when it was used for the experiments, and the institute states that mycoplasma testing is negative. Cells were cultured in DMEM medium (Gibco)
supplemented with 10% fetal bovine serum (Lanzhou Minhai Biotech. Ltd.). 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin were added to the medium during incubation. And cells were incubated at 37˚C in the humidified atmosphere of 5% CO 2 and 95% air.
MTT Assay and Cell Cycle Analysis
The effect of TIP-6 on cell viability was determined by MTT assay. Cells were After dehydration, ultrathin sections were prepared using a Sorvall MT5000 microtome and collected on 150 mesh copper grids. At last, cells were stained with 1% uranyl acetate and/or lead citrate and images were captured with a JEOL 100CX transmission microscope camera.
Determination of Morphological Changes
Western Blot
Cells (2 × 10 6 cells) were untreated or treated with TIP-6 at the indicated concentration for 24 h and washed twice with PBS before addition of the cell lysis 
Molecular Modeling
The 
Statistical Analysis
All data were expressed as mean ± S.D. and analysis with Excel software. Every experiment was repeated at least three times. In each case, P value < 0.05 was considered statistically significant.
Results
Synthesis of Title Compound TIP-6
Bridgehead nitrogen heterocycles are of interest because they are important building blocks of natural and unnatural products and many of them possess important biological activities. Figure 1 ).
The Inhibition of TIP-6 on HepG2 Cell Viablibity
Cell viability was expressed as a percentage of control and the IC50 represented the concentration of TIP-6 at which the 50% of cells in each well were inhibited, and we got IC50 using GraphPad Prism. As expected, TIP-6 showed a significant inhibitory effect on cell viability (Figure 2 ) with an IC50 of 32.09 μM with 24h treatment. In the meantime, the same effect by TIP-6 on Hela cells did not be observed.
The Arrest of HepG2 Cells in G2/M-Phase
With the significant inhibition effect of TIP-6 on HepG2 cells viability was determined, the further examination of TIP-6 on the cell cycle of HepG2 cells was performed by flow cytometry and the results were summarized in Table 1 
Morphological Changes of HepG2 Cells Induced by TIP-6
The examination of cell morphological changes was conducted, which are characteristics of autophagy in cells. Cells were treated with 150 μM TIP-6 for 24 h, it was failed to exhibit chromatin condensation and nuclear fragmentation,which are characteristics of canonical apoptosis and demonstrated by the staining of the cells with Annexin V/7-AAD (Figure 3(A) ) and DAPI ( Figure   3(B) ), respectively.
The Formation of Autophagic Vacuoles and Accumulation of Acidic Vesicular Organelles in HepG2 Cells
Cells were stained with the lysosomotropic reagent AO to assess the maturation of autolysosomes. It was clearly manifested that the presence of autolysosomes appeared after the treatment of TIP-6 and the maturation of autolysosomes were indued by TIP-6 ( Figure 4(A) ). In addition, the Electron Microscope was Table 1 . Changes in cell phase of HepG2 cells treated with TIP-6 (n = 3, X S ± , %). employed to confirm the formation of vacuoles and to visualize the contained material in the autophagic vacuoles. As shown in (Figure 4(B) ), well-shaped vacuoles were formed in HepG2 cells treated with 90 μM TIP-6 for 24 h, and it was in stark comparison to the control in which HepG2 cells exposed with 90 μM TIP-6 and 10 μM 3-MA (3-methyladenine).
The Effect of TIP-6 on the Expression of Autophagy-Related Proteins
LC3, a mammalian homolog of yeast Atg8, is the only reliable marker of autophagosomes, and Beclin-1 is also a mammalian ortholog of the yeast Atg6. This protein interacts with either BCL-2 or PI3K class III, playing a major role in the regulation of both autophagy and cell death. The protein levels of Bcl-2 and LC3
were detected by western blot. Expectedly, the results showed that LC-3 I/II and Beclin1 were up-regulated, while Bcl-2 was down-regulated ( Figure 5 ).
HepG2 cells were treated with different concentrations of TIP-6 for 24 h, and 30 µg of total protein was used to detect the interested proteins.
Modeling of the Binding of TIP-6 to Bcl-2 and Bcl-xL
Since the autophagy is initiated under certain circumstances when apoptosis is blocked, it suggested that TIP-6 may bind to Bcl-2 and Bcl-xL, two well-known major apoptosis regulators, and compromise their activity. The authors per- 
Discussion
The designed and synthesized TIP-6 which exhibited an anti-proliferative effect A number of small molecules had been reported capable of inhibiting the activities of Bcl-2 antiapoptotic proteins and promoting the autophagy in cancer cells [32] . These promising results prompted us to explore whether the TIP-6 employs a similar mode which bind to Bcl-2 antiapoptotic proteins in initiating and promoting the autophagy. The molecular docking assessed the binding affinity between TIP-6 and Bcl-2 or Bcl-xL. It was found that an appreciable high score in the binding mode of which the TIP-6 was well docked in the Bcl-2 active site. These indicated that TIP-6 initiated and promoted the autophagy in HepG2 cells by interacting with Bcl-2 antiapoptotic proteins.
In summary, the authors designed and synthesized TIP-6 which had pro- 
Conclusion
In this study, it was demonstrated that TIP-6 inhibited HepG2 cell proliferation, and this may due to the induced autophagy. Further investigations showed that TIP-6 down-regulated Bcl-2 and up-regulated PI3K class III, which plays a major role in the regulation of autophagy. And the most interesting is that docking
showed that TIP-6 may bind in the Bcl-2 active site. Unfortunately, we are unable to determine from these data to make sure that TIP-6 binds with Bcl-2, so more experiments need to be performed in the future.
